Acupuncture for Symptomatic care of Type 2 Diabetic Mellitus

Acupuncture for Symptomatic care of Type 2 Diabetic Mellitus: A Case-Series

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000940

Enrollment

Registered

2013-11-26

Start date

2013-11-01

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Treatment regimen: 2 times/week for 6 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Male and female subjects between the ages of 19 and 75 years 2. Those diagnosed with Type 2 diabetes 3. Those with symptoms of diabetes-related complications 4. Those who would agree to participate in this trail after being duly informed about the purpose and nature of the study and provide their written, informed consent

Exclusion criteria

Exclusion criteria: 1. Those deemed ineligible to participate in this clinical trial by the investigator due to the following diseases - Cerebrovascular diseases (stroke, cerebral infarction, brain tumors, vascular malformations, etc.); heart diseases (myocardial infarction, angina, valvular heart disease, congestive heart failure, etc.); and those diagnosed with malignant tumors - Acute and chronic liver disease - Hemorrhagic disease - Drug dependence and alcoholism - -Active tuberculosis and other infectious diseases 2. Those with HbA1c level greater than 11% 3. Those following irregular medication use for blood glucose control, within the past 4 weeks (within ±25% of dosage change for the default drug) 4. Those who have received herbal medicine treatment (acupuncture, moxibustion, cupping, herbal medicine) within the past 4 weeks 5. Those who have participated in another clinical trial in the past 3 months 6. Pregnant or lactating women as well as those planning to conceive 7. Others who have been deemed ineligible by the study investigator

Design outcomes

Primary

Measure	Time frame
Measure Yourself Medical Outcome Profile; MYMOP2	—

Secondary

Measure	Time frame
EQ-5D(EuroQoL-5 Dimensions) ;Beck Depression Inventory (BDI);FBS, HbA1c ;Patient Global Impression of Change (PGIC);Medication Quantification Scale (MQS);Questinnaire of pattern indentificatiion;Adverse events	—

Countries

Korea, Republic of

Contacts

Public ContactKyungmin Shin

Korea Institute of Oriental Medicine

kyungmin7221@gmail.com+82-42-223-4051

Outcome results